JPWO2021202734A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021202734A5 JPWO2021202734A5 JP2022559909A JP2022559909A JPWO2021202734A5 JP WO2021202734 A5 JPWO2021202734 A5 JP WO2021202734A5 JP 2022559909 A JP2022559909 A JP 2022559909A JP 2022559909 A JP2022559909 A JP 2022559909A JP WO2021202734 A5 JPWO2021202734 A5 JP WO2021202734A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- group
- antigen
- composition
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063002682P | 2020-03-31 | 2020-03-31 | |
| US63/002,682 | 2020-03-31 | ||
| PCT/US2021/025174 WO2021202734A2 (en) | 2020-03-31 | 2021-03-31 | Universal influenza vaccine using nucleoside-modifield mrna |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023550666A JP2023550666A (ja) | 2023-12-05 |
| JPWO2021202734A5 true JPWO2021202734A5 (https=) | 2024-04-10 |
| JP2023550666A5 JP2023550666A5 (https=) | 2024-04-10 |
Family
ID=77929131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559909A Pending JP2023550666A (ja) | 2020-03-31 | 2021-03-31 | ヌクレオシド修飾ｍＲＮＡを使用する汎用インフルエンザワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230181715A1 (https=) |
| EP (1) | EP4126032A4 (https=) |
| JP (1) | JP2023550666A (https=) |
| KR (1) | KR20230104068A (https=) |
| CN (1) | CN116583296A (https=) |
| AU (1) | AU2021246064A1 (https=) |
| CA (1) | CA3178344A1 (https=) |
| MX (1) | MX2022012251A (https=) |
| WO (1) | WO2021202734A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12194089B2 (en) | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| US20240156946A1 (en) | 2020-12-22 | 2024-05-16 | CureVac SE | Rna vaccine against sars-cov-2 variants |
| CN117534738B (zh) * | 2022-07-15 | 2024-08-09 | 中山大学·深圳 | 一种季节性甲型流感通用Mosaic重组抗原及其疫苗和应用 |
| EP4604995A1 (en) | 2022-10-17 | 2025-08-27 | BioNTech SE | Combination vaccines against coronavirus infection, influenza infection, and/or rsv infection |
| WO2024089638A1 (en) | 2022-10-28 | 2024-05-02 | Glaxosmithkline Biologicals Sa | Nucleic acid based vaccine |
| CN118256522A (zh) * | 2022-12-19 | 2024-06-28 | 斯微(上海)生物科技股份有限公司 | 一种广谱流感mRNA疫苗 |
| EP4669348A1 (en) | 2023-02-24 | 2025-12-31 | BioNTech SE | IMMUNOGENEOUS COMPOSITIONS |
| WO2025092866A1 (zh) * | 2023-10-31 | 2025-05-08 | 仁景(苏州)生物科技有限公司 | 一种多价流感mRNA疫苗 |
| WO2026047603A1 (en) | 2024-08-28 | 2026-03-05 | BioNTech SE | Sars-cov-2 immunogenic compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070224205A1 (en) * | 2006-03-07 | 2007-09-27 | Powell Thomas J | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| WO2010060430A2 (en) * | 2008-11-28 | 2010-06-03 | Statens Serum Institut | Optimized influenza vaccines |
| AU2014310935B2 (en) * | 2013-08-21 | 2019-11-21 | CureVac SE | Combination vaccine |
| US20180303925A1 (en) * | 2015-04-27 | 2018-10-25 | The Trustees Of The University Of Pennsylvania | Nucleoside-Modified RNA For Inducing an Adaptive Immune Response |
| WO2017070620A2 (en) * | 2015-10-22 | 2017-04-27 | Modernatx, Inc. | Broad spectrum influenza virus vaccine |
| WO2018081638A1 (en) * | 2016-10-27 | 2018-05-03 | The Trustees Of The University Of Pennsylvania | Nucleoside-modified rna for inducing an adaptive immune response |
| WO2018089851A2 (en) * | 2016-11-11 | 2018-05-17 | Modernatx, Inc. | Influenza vaccine |
| US11576962B2 (en) * | 2017-12-21 | 2023-02-14 | Green Biomed, Inc. | Cross-immunizing antigen vaccine and method for preparation thereof |
-
2021
- 2021-03-31 US US17/995,207 patent/US20230181715A1/en active Pending
- 2021-03-31 AU AU2021246064A patent/AU2021246064A1/en active Pending
- 2021-03-31 CN CN202180037013.4A patent/CN116583296A/zh active Pending
- 2021-03-31 JP JP2022559909A patent/JP2023550666A/ja active Pending
- 2021-03-31 CA CA3178344A patent/CA3178344A1/en active Pending
- 2021-03-31 MX MX2022012251A patent/MX2022012251A/es unknown
- 2021-03-31 KR KR1020227037814A patent/KR20230104068A/ko active Pending
- 2021-03-31 EP EP21780181.0A patent/EP4126032A4/en active Pending
- 2021-03-31 WO PCT/US2021/025174 patent/WO2021202734A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nobusawa et al. | Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses | |
| Deng et al. | Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses | |
| US12364746B2 (en) | Mosaic influenza virus hemagglutinin polypeptides and uses thereof | |
| JP2023088962A (ja) | インフルエンザウイルスワクチン及びその使用 | |
| CN102257135B (zh) | 流感疫苗的生产 | |
| Stevens et al. | Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity | |
| CA2805505C (en) | Chimeric influenza viruses having reduced ability to reassort with other influenza viruses and uses thereof | |
| JP7654625B2 (ja) | タンパク質加水分解標的ウイルス、その生ワクチン及びその作製方法と用途 | |
| JPWO2021239880A5 (https=) | ||
| US20220072120A1 (en) | Nanoparticle-based influenza virus vaccines and uses thereof | |
| WO2020264141A1 (en) | Influenza virus neuraminidase and uses thereof | |
| JP2020504764A5 (https=) | ||
| JP2014504500A5 (https=) | ||
| JP2016199557A (ja) | インフルエンザウイルスワクチン及びその使用 | |
| Guo et al. | Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza | |
| CN119947747A (zh) | 流感病毒疫苗 | |
| JPWO2021202734A5 (https=) | ||
| US20230285537A1 (en) | Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same | |
| Zavyalova et al. | Aptamers to hemagglutinin: A novel tool for influenza virus recognition and neutralization | |
| US12350325B2 (en) | Recombinant high growth rate influenza virus comprising mutations in M1, NS2, and PB2 | |
| JPWO2022099003A5 (https=) | ||
| US12569550B2 (en) | Hemagglutinin modifications for improved influenza vaccine production | |
| Nuwarda et al. | An Overview of Influenza Viruses and Vaccines. Vaccines 2021, 9, 1032 | |
| RU2025121933A (ru) | Нуклеиновые кислоты и их применение | |
| CN121001738A (zh) | 流感病毒疫苗 |